Andreas Neubauer

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 29

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Niklas Gremke, Fiona R Rodepeter, Julia Teply-Szymanski, Sebastian Griewing, Jelena Boekhoff, Alina Stroh, Thomas S Tarawneh, Jorge Riera-Knorrenschild, Christina Balser, Akira Hattesohl, Martin Middeke, Petra Ross, Anne-Sophie Litmeyer, Marcel Romey, Thorsten Stiewe, Thomas Wündisch, Andreas Neubauer, Carsten Denkert, Uwe Wagner, Elisabeth K M Mack
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board Analysis. Cancers 16 (8) (2024)
Wolfgang Fischbach, Andreas Neubauer, Gabriele Reinartz
[Gastrointestinal mucosa-associated lymphoma]. Innere Medizin (Heidelberg, Germany) 65 (7) (2024)
Niklas Gremke, Fiona R Rodepeter, Julia Teply-Szymanski, Sebastian Griewing, Jelena Boekhoff, Alina Stroh, Thomas S Tarawneh, Jorge Riera-Knorrenschild, Christina Balser, Akira Hattesohl, Martin Middeke, Petra Ross, Anne-Sophie Litmeyer, Marcel Romey, Thorsten Stiewe, Thomas Wündisch, Andreas Neubauer, Carsten Denkert, Uwe Wagner, Elisabeth K M Mack
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board Analysis. Cancers 16 (8) (2024)
Fabian Acker, Jörg Chromik, Emily Tiedjen, Sebastian Wolf, Jonas B Vischedyk, Philipp Makowka, Julius C Enssle, Khouloud Kouidri, Martin Sebastian, Björn Steffen, Thomas Oellerich, Hubert Serve, Andreas Neubauer, Jonas A Schäfer, Jörg T Bittenbring
Real-world effectiveness of first-line azacitidine or decitabine with or without venetoclax in acute myeloid leukemia patients unfit for intensive therapy. European journal of haematology (2024)
Wolfgang Fischbach, Andreas Neubauer, Gabriele Reinartz
[Gastrointestinal mucosa-associated lymphoma]. Innere Medizin (Heidelberg, Germany) (2024)
Wolfgang Fischbach, Andreas Neubauer, Gabriele Reinartz
[Gastrointestinal mucosa-associated lymphoma]. Innere Medizin (Heidelberg, Germany) 65 (7) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Fabio Efficace, Michal Kicinski, Corneel Coens, Stefan Suciu, Walter J F M van der Velden, Richard Noppeney, Sylvain P Chantepie, Laimonas Griskevicius, Andreas Neubauer, Ernesta Audisio, Mario Luppi, Stephan Fuhrmann, Robin Foà, Martina Crysandt, Gianluca Gaidano, Radovan Vrhovac, Adriano Venditti, Eduardus F M Posthuma, Anna Candoni, Fréderic Baron, Olivier Legrand, Andrea Mengarelli, Paola Fazi, Marco Vignetti, Anne Giraut, Pierre W Wijermans, Gerwin Huls, Michael Lübbert
Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial. Blood 144 (5) (2024)
Christoph Röllig, Björn Steffen, Christoph Schliemann, Jan-Henrik Mikesch, Nael Alakel, Regina Herbst, Mathias Hänel, Richard Noppeney, Maher Hanoun, Martin Kaufmann, Barbora Weinbergerová, Kerstin Schäfer-Eckart, Tim Sauer, Andreas Neubauer, Andreas Burchert, Claudia D Baldus, Jolana Mertová, Edgar Jost, Dirk Niemann, Jan Novák, Stefan W Krause, Sebastian Scholl, Andreas Hochhaus, Gerhard Held, Tomas Szotkowski, Andreas Rank, Christophe Schmid, Lars Fransecky, Sabine Kayser, Markus Schaich, Michael Kramer, Frank Fiebig, Annett Haake, Johannes Schetelig, Jan Moritz Middeke, Friedrich Stölzel, Uwe Platzbecker, Christian Thiede, Carsten Muller-Tidow, Wolfgang E Berdel, Gerhard Ehninger, Jiří Mayer, Hubert Serve, Martin Bornhäuser
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Fabio Efficace, Michal Kicinski, Corneel Coens, Stefan Suciu, Walter J F M van der Velden, Richard Noppeney, Sylvain P Chantepie, Laimonas Griskevicius, Andreas Neubauer, Ernesta Audisio, Mario Luppi, Stephan Fuhrmann, Robin Foà, Martina Crysandt, Gianluca Gaidano, Radovan Vrhovac, Adriano Venditti, Eduardus F M Posthuma, Anna Candoni, Fréderic Baron, Olivier Legrand, Andrea Mengarelli, Paola Fazi, Marco Vignetti, Anne Giraut, Pierre W Wijermans, Gerwin A Huls, Michael Lübbert
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial. Blood (2024)
Kai Zhao, Madita Braun, Leonie Meyer, Katharina Otte, Hartmann Raifer, Frederik Helmprobst, Vincent Möschl, Axel Pagenstecher, Hans Urban, Michael W Ronellenfitsch, Joachim P Steinbach, Jelena Pesek, Bernhard Watzer, Wolfgang A Nockher, Regina Verena Taudte, Andreas Neubauer, Christopher Nimsky, Jörg Walter Bartsch, Tillmann Rusch
A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1. Cells 13 (7) (2024)
Julius C Enßle, Sebastian Wolf, Sebastian Scheich, Sarah Weber, Michael Kramer, Leo Ruhnke, Christoph Schliemann, Jan-Henrik Mikesch, Stefan W Krause, Tim Sauer, Maher Hanoun, Hans Christian Reinhardt, Sabrina Kraus, Martin Kaufmann, Mathias Hänel, Lars Fransecky, Andreas Burchert, Andreas Neubauer, Martina Crysandt, Edgar Jost, Dirk Niemann, Kerstin Schäfer-Eckart, Gerhard Held, Ulrich Kaiser, Maxi Wass, Markus Schaich, Carsten Muller-Tidow, Uwe Platzbecker, Claudia D Baldus, Martin Bornhäuser, Christoph Röllig, Hubert Serve, null null, Björn Steffen
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience. British journal of cancer (2023)
Falk Heidenreich, Bose Falk, Henning Baldauf, Carolin Massalski, Gesine Schäfer, Elke Rücker-Braun, Heidi Altmann, Jürgen Sauter, Ute Solloch, Vinzenz Lange, Friedrich Stölzel, Christoph Röllig, Jan Moritz Middeke, Malte von Bonin, Christian Thiede, Kerstin Schäfer-Eckart, Carsten Muller-Tidow, Stefan W Krause, Sabrina Kraus, Martin Kaufmann, Mathias Hänel, Hubert Serve, Andreas Neubauer, Martin Bornhäuser, Alexander H Schmidt, Johannes Schetelig
Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia. Blood advances (2023)
Elisabeth K M Mack, Sören Hartmann, Petra Ross, Ellen Wollmer, Christoph Mann, Andreas Neubauer, Cornelia Brendel, Jörg Hoffmann
Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells. Annals of hematology 101 (4) (2022)
Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, Stephen Strickland, Eunice S Wang, Ehab Atallah, Gary J Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Recher, Sung Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee-Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramon Tiu, Mark J Levis
Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial. Blood 139 (23) (2022)
Joerg Hoffmann, Rojin Etati, Cornelia Brendel, Andreas Neubauer, Elisabeth K M Mack
The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia. Diagnostics (Basel, Switzerland) 12 (8) (2022)
Jan Moritz Middeke, Klaus H Metzeler, Christoph Röllig, Michael Kramer, Jan-Niklas Eckardt, Sebastian Stasik, Philipp A Greif, Karsten Spiekermann, Maja Rothenberg-Thurley, Utz Krug, Jan Braess, Alwin Kraemer, Andreas Hochhaus, Tim Henrik Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Dennis Görlich, Cristina M Sauerland, Kerstin Schaefer-Eckart, Christoph Schliemann, Stefan W Krause, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Martin Kaufmann, Desiree Kunadt, Bernhard J Woermann, Katja Sockel, Malte von Bonin, Tobias Herold, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E Berdel, Hubert Serve, Claudia D Baldus, Gerhard Ehninger, Johannes Schetelig, Wolfgang Hiddemann, Martin Bornhäuser, Friedrich Stölzel, Christian Thiede
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: Results from a large multicenter study. Blood advances (2021)
Andreas Burchert, Stephan K Metzelder, Andreas Neubauer, Michael Wittenberg, Carmen Schade-Brittinger
Reply to S. Fuji. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (12) (2021)
Andreas Neubauer, Johannes Johow, Elisabeth K M Mack, Andreas Burchert, Damaris Meyn, Andrea Kadlubiec, Iuliu Torje, Hinnerk Wulf, Claus F Vogelmeier, Joachim Hoyer, Chrysanthi Skevaki, Ralf Michael Muellenbach, Christian Keller, Carmen Schade-Brittinger, Caroline Rolfes, Thomas Wiesmann
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS). Leukemia 35 (10) (2021)
Sebastian Stasik, Jan-Niklas Eckardt, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Jan M Middeke, Christian Thiede, null null
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia. Blood advances 5 (17) (2021)
Leonie Gebauer, Andrea Nist, Marco Mernberger, Thorsten Stiewe, Roland Moll, Kathleen Stabla, Uwe Klinge, Elisabeth K M Mack, Cornelia Brendel, Andreas Neubauer
Superior Overall Survival in Patients with Colorectal Cancer, Regular Aspirin Use, and Combined Wild-Type PIK3CA and KRAS-Mutated Tumors. Cancers 13 (19) (2021)
Jan-Niklas Eckardt, Sebastian Stasik, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim Henrik Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E Berdel, Jiří Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Friedrich Stölzel, Frank Kroschinsky, Johannes Schetelig, Martin Bornhäuser, Christian Thiede, Jan Moritz Middeke
Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia. Cancers 13 (9) (2021)
Franziska Taube, Julia Annabell Georgi, Michael Kramer, Sebastian Stasik, Jan Moritz Middeke, Christoph Röllig, Utz Krug, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Tim Henrik Brümmendorf, Ralph Naumann, Andreas Petzold, Roger Mulet-Lazaro, Peter J M Valk, Bjoern Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W Krause, Mathias Hänel, Richard Noppeney, Ulrich Kaiser, Claudia Baldus, Martin Kaufmann, Sylvia Herold, Friedrich Stölzel, Katja Sockel, Malte von Bonin, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E Berdel, Hubert Serve, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede
CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome. Blood (2021)
Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, Philipp Reichert, Calin-Petru Manta, Mohamed H S Awwad, Sandra Sauer, Uta Bertsch, Britta Besemer, Roland Fenk, Mathias Hänel, Markus Munder, Katja C Weisel, Igor W Blau, Andreas Neubauer, Carsten Müller-Tidow, Marc S Raab, Hartmut Goldschmidt, Stefanie Huhn, null For The German-Speaking Myeloma Multicenter Group Gmmg
Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment. Cancers 12 (8) (2020)
Viviane Ponath, Miriam Frech, Mathis Bittermann, Reem Al Khayer, Andreas Neubauer, Cornelia Brendel, Elke Pogge von Strandmann
The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC. Cancers 12 (10) (2020)
Laura Budau, Christian Wilhelm, Roland Moll, Jörg Jäkel, Carsten Hirt, Gottfried Dölken, Georg Maschmeyer, Ellen Neubauer, Konstantin Strauch, Andreas Burchert, Michael Herold, Andreas Neubauer
Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial. Journal of cancer research and clinical oncology 145 (8) (2019)

Andreas Neubauer.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Neubauer